Form 4 for ANVS Annovis Bio, Inc.
Accepted 2025-11-12 00:00:00 ET · period of report 2025-10-28 · accession 0001104659-25-109906 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-12 | 2025-10-28 | ANVS | Maccecchini Maria-Luisa | Pres, CEO, Dir | P - Purchase | $2.05 | +97.6K | 1.21M | +9% | +$200.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-28 | P | A | 97,561 | $2.05 | 1,212,020 | D | — | — |